193 related articles for article (PubMed ID: 12362314)
1. [Association of plasminogen activator inhibitor-1 gene 4G/5G polymorphism and coronary heart disease in Chinese patients].
Guan L; Ji X; Wang J; Zhang A; Zhang Y; Zhao L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Oct; 19(5):393-6. PubMed ID: 12362314
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor-1 4G/5G gene polymorphism in patients with myocardial or cerebrovascular infarction in Tianjin, China.
Zhan M; Zhou Y; Han Z
Chin Med J (Engl); 2003 Nov; 116(11):1707-10. PubMed ID: 14642142
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between plasminogen activator inhibitor-1 gene 4G/5G polymorphism and type 2 diabetic nephropathy in Chinese Han patients in Guangdong Province].
Liu SQ; Xue YM; Yang GC; He FY; Zhao XS
Di Yi Jun Yi Da Xue Xue Bao; 2004 Aug; 24(8):904-7. PubMed ID: 15321757
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor-1 4G/5G gene polymorphism and coronary artery disease in the Chinese Han population: a meta-analysis.
Li YY
PLoS One; 2012; 7(4):e33511. PubMed ID: 22496752
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor-1 gene polymorphism 4G/4G genotype and lupus nephritis in Chinese patients.
Wang AY; Poon P; Lai FM; Yu L; Choi PC; Lui SF; Li PK
Kidney Int; 2001 Apr; 59(4):1520-8. PubMed ID: 11260416
[TBL] [Abstract][Full Text] [Related]
6. The 4G/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes.
Iwai N; Shimoike H; Nakamura Y; Tamaki S; Kinoshita M
Atherosclerosis; 1998 Jan; 136(1):109-14. PubMed ID: 9544737
[TBL] [Abstract][Full Text] [Related]
7. 4G/5G promoter polymorphism of plasminogen activator inhibitor-1, lipid profiles, and ischemic stroke.
Chen CH; Eng HL; Chang CJ; Tsai TT; Lai ML; Chen HY; Liu CJ; Lin TM
J Lab Clin Med; 2003 Aug; 142(2):100-5. PubMed ID: 12960956
[TBL] [Abstract][Full Text] [Related]
8. Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction.
Fu L; Jin H; Song K; Zhang C; Shen J; Huang Y
Chin Med J (Engl); 2001 Mar; 114(3):266-9. PubMed ID: 11780311
[TBL] [Abstract][Full Text] [Related]
9. Relationship of plasminogen activator inhibitor 1 gene 4G/5G polymorphisms to hypertension in Korean women.
Kim KN; Kim KM; Kim BT; Joo NS; Cho DY; Lee DJ
Chin Med J (Engl); 2012 Apr; 125(7):1249-53. PubMed ID: 22613596
[TBL] [Abstract][Full Text] [Related]
10. Association of PAI-1 gene promoter 4g/5g polymorphism with plasma PAI-1 activity in Chinese patients with and without hypertension.
Jeng JR
Am J Hypertens; 2003 Apr; 16(4):290-6. PubMed ID: 12670745
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor-1 5G/5G genotype is associated with early spontaneous recanalization of the infarct-related artery in patients presenting with acute ST-elevation myocardial infarction.
Cagliyan CE; Yuregir OO; Balli M; Tekin K; Akilli RE; Bozdogan ST; Turkmen S; Deniz A; Baykan OA; Aslan H; Cayli M
Coron Artery Dis; 2013 May; 24(3):196-200. PubMed ID: 23283030
[TBL] [Abstract][Full Text] [Related]
12. Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.
Abboud N; Ghazouani L; Saidi S; Ben-Hadj-Khalifa S; Addad F; Almawi WY; Mahjoub T
Genet Test Mol Biomarkers; 2010 Feb; 14(1):23-7. PubMed ID: 19929406
[TBL] [Abstract][Full Text] [Related]
13. Allelic frequency of the PAI-1 4G/5G promoter polymorphism in patients with type 2 diabetes mellitus and lack of association with PAI-1 plasma levels.
Zietz B; Buechler C; Drobnik W; Herfarth H; Schölmerich J; Schäffler A
Endocr Res; 2004 Aug; 30(3):443-53. PubMed ID: 15554360
[TBL] [Abstract][Full Text] [Related]
14. Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis.
Gürkan A; Emingil G; Saygan BH; Cinarcik S; Atilla G; Köse T; Berdeli A
J Periodontol; 2007 Jul; 78(7):1256-63. PubMed ID: 17608581
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between the 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and the pathogenesis of pregnancy-induced hypertension syndrome].
Guan LX; Du XY; Wang JX; Wang RL; Wu ZL; Jiang H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):173-5. PubMed ID: 15079805
[TBL] [Abstract][Full Text] [Related]
16. Role of functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children.
Haralambous E; Hibberd ML; Hermans PW; Ninis N; Nadel S; Levin M
Crit Care Med; 2003 Dec; 31(12):2788-93. PubMed ID: 14668616
[TBL] [Abstract][Full Text] [Related]
17. Association of plasminogen activator inhibitor-1 gene polymorphism and type 2 diabetic nephropathy.
Xu F; Liu H; Sun Y
Ren Fail; 2016; 38(1):157-62. PubMed ID: 26616527
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity.
Castelló R; España F; Vázquez C; Fuster C; Almenar SM; Aznar J; Estellés A
Thromb Res; 2006; 117(5):487-92. PubMed ID: 15907980
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor type 1 serum levels and 4G/5G gene polymorphism in morbidly obese Hispanic patients with non-alcoholic fatty liver disease.
Espino A; Villagrán A; Vollrath V; Hanckes P; Salas R; Farah A; Solís N; Pizarro M; Escalona A; Boza C; Pérez G; Carrasco G; Padilla O; Miquel JF; Nervi F; Chavez-Tapia NC; Arab JP; Alvarez-Lobos M; Arrese M; Riquelme A
Ann Hepatol; 2011; 10(4):493-501. PubMed ID: 21911891
[TBL] [Abstract][Full Text] [Related]
20. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
